DDX3X and central nervous system cancer: From a pathological point of view, overexpression of DDX3X is positively correlated with pathological classification in glioma, meningioma and PDAC [27, 77, 83], indicating that DDX3X has the potential to differentiate the degrees of pathological classification of tumours.